Articles From: Oxygen Biotherapeutics Receives $6 Million in Net Proceeds from Warrant Exercises to Qunar to Report Third Quarter 2013 Financial Results on November 19, 2013


Oxygen Biotherapeutics, Inc. , (NASDAQ:OXBT) a developer of oxygen-carrying therapeutics, today announced the Company has received approximately $6 million through the exercise of 2,294,874 warrants between November 4, 2013 and November 6, 2013.
Sign-up for Oxygen Biotherapeutics Receives $6 Million in Net Proceeds from Warrant Exercises investment picks
Levi & Korsinsky notifies investors of Santarus, Inc. (“Santarus” or the “Company”) (Nasdaq:SNTS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Salix Pharmaceuticals, Ltd.
Sign-up for LEVI & KORSINSKY, LLP Notifies Investors of SANTARUS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with Sale of the Company to Salix Pharmaceuticals, Ltd. investment picks
2013/11/8
SAN ANTONIO, Texas , Nov.
Sign-up for Pioneer Energy Services to Present at the Stephens Fall Investment Conference and the Jefferies 2013 Global Energy Conference investment picks
By Barbara Kollmeyer, MarketWatch MADRID (MarketWatch) -- Stock futures moved slightly higher on Friday ahead of a key jobs report, with speeches from Federal Reserve Chairman Ben Bernanke and other central bank officials also on tap.
Sign-up for UPDATE: Stock futures edge up ahead of payrolls data investment picks
Lionsgate reports second quarter fiscal 2014 revenue of $498.7 million, adjusted EBITDA of $56.5 million and adjusted net income of $25.4 million or $0.19 adjusted basic EPS Canada NewsWire Company Reports Second Quarter Free Cash Flow of $84.9 Million SANTA MONICA, Calif.
Sign-up for Lionsgate reports second quarter fiscal 2014 revenue of $498.7 million, adjusted EBITDA of $56.5 million and adjusted net income of $25.4 million or $0.19 adjusted basic EPS investment picks
U.S. stock futures moved slightly higher Friday ahead of a key jobs report, with speeches from Federal Reserve Chairman Ben Bernanke and other central-bank officials also on tap.
Sign-up for U.S. Stock Futures Edge Higher investment picks
SALT LAKE CITY, Nov.
Sign-up for Myriad Genetics to Present at the 2013 Credit Suisse Annual Healthcare Conference investment picks
Compared with peers nationally, more Hartford area small business owners are likely to have hired in the past 12 months, even though they are less optimistic about their local economy 1 , according to The Hartford’s 2013 Small Business Success Study .
Sign-up for Hartford Small Businesses Beat National Hiring Average, But Less Optimistic On Local Economy, The Hartford Finds investment picks
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced it will host a teleconference and webcast with management to discuss the third quarter 2013 financial results, provide an update on the Company's business, and discuss expectations for the future.
Sign-up for Spectrum Pharmaceuticals Announces Third Quarter 2013 Financial Results Teleconference and Webcast investment picks
2013/11/8
WPP (NASDAQ:WPPGY) announces that it has agreed to acquire Bottle Rocket, a full-service mobile solution provider in the US.
Sign-up for WPP Acquires Bottle Rocket in the United States investment picks
2013/11/8
NEW PROVIDENCE, N.J. , Nov.
Sign-up for AXION Schedules Conference Call to Discuss 2013 Third Quarter Results investment picks
2013/11/8
Company Reports Second Quarter Free Cash Flow of $84.9 Million SANTA MONICA, Calif.
Sign-up for LIONSGATE REPORTS SECOND QUARTER FISCAL 2014 REVENUE OF $498.7 MILLION, ADJUSTED EBITDA OF $56.5 MILLION AND ADJUSTED NET INCOME OF $25.4 MILLION OR $0.19 ADJUSTED BASIC EPS investment picks
2013/11/8
LOS ANGELES, Nov.
Sign-up for Image Entertainment Nabs Drive Hard investment picks
UnitedHealth Group (NYSE: UNH) announced today that its Board of Directors, at its meeting on November 7, 2013, authorized payment of a quarterly shareholder dividend of $0.28 per share in the fourth quarter of 2013.
Sign-up for UnitedHealth Group Board Authorizes Payment of Quarterly Dividend to Shareholders investment picks
Management will discuss pivotal trial plans for its drug candidate Iomab™-B and its potential as a new treatment paradigm for certain blood cancers NEW YORK , Nov.
Sign-up for Actinium Pharmaceuticals To Host Corporate Update And Virtual Roadshow Conference Call On November 11 investment picks
2013/11/8
LINCOLN, R.I., Nov.
Sign-up for Costa Inc. to be Acquired by Essilor International investment picks
2013/11/8
Revenue increases 30% in third quarter to $22.4 million FAIRFAX, Va.
Sign-up for Geeknet Announces Third Quarter 2013 Financial Results investment picks
WEX Inc. (NYSE: WEX), a leading provider of corporate payment solutions, today announced that it plans to acquire the assets of ExxonMobil’s European commercial fuel card (“Esso Card”) program through a majority owned joint venture, WEX Europe Services Limited.
Sign-up for WEX Announces Plans to Acquire ExxonMobil’s European Commercial Fuel Card Program investment picks
/R E P E A T --
Sign-up for /R E P E A T -- Crombie REIT Q3 Fiscal 2013 Conference Call/ investment picks
2013/11/8
OFS Capital Corporation (NASDAQ:OFS) (“OFS Capital” or the “Company”) today announced its financial results for the fiscal quarter ended September 30, 2013, OFS Capital’s third full quarter of operations following its initial public offering (“IPO”) in November 2012.
Sign-up for OFS Capital Corporation Announces Third Quarter 2013 Financial Results investment picks
HOUSTON, Nov.
Sign-up for ENGlobal Reports Third Quarter 2013 Results investment picks
NEW DELHI--Tata Motors Ltd.
Sign-up for Tata Motors Second-Quarter Net Profit Jumps 71% investment picks
777-300ER to provide Ethiopian flag-carrier with additional capacity on key routes SEATTLE , Nov.
Sign-up for Boeing Delivers Ethiopian Airlines' First 777-300ER investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Oxygen Biotherapeutics Receives $6 Million in Net Proceeds from Warrant Exercises to Qunar to Report Third Quarter 2013 Financial Results on November 19, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity